Clinical Trials in Arizona

Showing 401-420 of 8,032 trials

RECRUITINGPHASE231 miles

PurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS Aspiration Samples

NCT04683315

This is an open-label, phase II study in patients with resectable and borderline resectable pancreatic cancer.

Pancreatic Cancer

Medical College of Wisconsin84 participantsStarted Apr 2021

Scottsdale, Arizona, United States • Milwaukee, Wisconsin, United States

ACTIVE_NOT_RECRUITINGPHASE331 miles

Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery

NCT01349322

RATIONALE: It is not yet know whether higher per daily radiation therapy is equally as effective as standard per daily radiation therapy in treating breast cancer. PURPOSE: This randomized phase III trial studies how well an accelerated course of higher per daily radiation therapy with concomitant boost works compared to standard per daily radiation therapy with a sequential boost in treating patients with early-stage breast cancer that was removed by surgery.

Breast Cancer

Radiation Therapy Oncology Group2,354 participantsStarted May 2011

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Scottsdale, Arizona, United States +412 more locations

PurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS Aspiration Samples

Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery

Find Trials by Condition in Arizona

A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

DISCOVERY of Risk Factors for Type 2 Diabetes in Youth

Trifecta-Lung cfDNA-MMDx Study

Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents

Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer

Collection and Storage of Tissue and Blood Samples From Patients With Cancer

FOLFIRI or Modified FOLFIRI and Veliparib as Second Line Therapy in Treating Patients With Metastatic Pancreatic Cancer

Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

A Study to Assess the Long-term Safety and Efficacy of ATB200/AT2221 in Adult Subjects With Late-Onset Pompe Disease (LOPD)

Personalized Reduction of Chemotherapy Intensity Through ctDNA Evaluation for the Treatment of Patients With Advanced Hodgkin Lymphoma

Olutasidenib for the Treatment of Patients With IDH1 Mutated AML, MDS or CMML After Donor Hematopoietic Cell Transplant

Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer

A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma

A Study to Evaluate the Effect of Budesonide, Glycopyrronium, Formoterol Fumarate (BGF) Metered Dose Inhaler (MDI), Budesonide and Formoterol Fumarate (BFF) MDI and Placebo MDI on Exercise Parameters in Participants With Chronic Obstructive Pulmonary Disease (COPD).

Lumason® Infusion vs. Bolus Administrations

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A

Systemic and Topical Antivirals for Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes